MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to rise 24.44% to -78 cents per share on August 07

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q2'25

Est.

$-0.78

Q1'25

Beat

by $0.13

Q4'24

Missed

by $0.12

Q3'24

Missed

by $0.12

Q2'24

Missed

by $0.11

The last earnings report on May 13 showed earnings per share of -62 cents, beating the estimate of -75 cents. With 1.38M shares outstanding, the current market capitalization sits at 3.10B.

View a ticker or compare two or three

Compare

MLTX